With autoradiographic and cytophotometric methods, the labelling index and ploidy pattern of the cells of the lacrimal gland, the glandula orbitalis externa and the glandula infraorbitalis of male and female rats of different ages (1,3,6 and 12 months) were investigated. The nuclei of the lacrimal glands showed a predominantly diploid pattern in both sexes. Only the 12-month-old male and female rats showed a small number of tetraploid nuclei In contrast, beginning with 3 months, both male and female rats exhibited a large number of tetraploid nuclei in the glandula orbitalis externa and glandula infraorbitalis. In addition, the female rats displayed round nuclei and the male rats exhibited dumb-bell-shaped nuclei. The dumbbell-shaped nuclei in the males were a result of what appeared to be polyploidisation. With the increase in polyploidisation, there was a simultaneous decrease in the DNA content and an increase in the labelling index. This indicated that these cells had a decreased turnover. The mechanism for the apparent polyploidisation of the male rats, beginning in the 3rd month, is discussed.

Keywords:
Rat, Gland cells, Cytophotometry, Autoradiography, Polyploidisation, DNA content
This content is only available via PDF.
© 1972 S. Karger AG, Basel
1972
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.